DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes out a prior overhead resistance point, then it's free to find new buyers and momentum players who can ultimately push the stock significantly higher.

Breakout candidates are something that I tweet about on a daily basis. I frequently tweet out high-probability setups, breakout plays and stocks that are acting technically bullish. These are the stocks that often go on to make monster moves to the upside. What's great about breakout trading is that you focus on trend, price and volume. You don't have to concern yourself with anything else. The charts do all the talking.

Trading breakouts is not a new game on Wall Street. This strategy has been mastered by legendary traders such as William O'Neal, Stan Weinstein and Nicolas Darvas. These pros know that once a stock starts to break out above past resistance levels and hold above those breakout prices, then it can easily trend significantly higher.

With that in mind, here's a look at five stocks that are setting up to break out and possibly trade higher from current levels.

vTv Therapeutics

Image placeholder title

One biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is vTv Therapeutics (VTVT) - Get Report , which engages in the discovery and development of orally administered small-molecule drug candidates. This stock is down modestly over the last month, with shares off by just 5%.

If you take a look at the chart for vTv Therapeutics you'll notice that this stock recently formed a double bottom chart pattern, after shares found some buying interest at $7.42 to $7.50 a share. Following that potential bottom, shares of vTv Therapeutics have started to uptrend a bit with the stock moving back above its 20-day moving average of $8.87 a share. That slight uptrend is now starting to push this stock within range of triggering a big breakout trade above some key near-term overhead resistance levels.

Traders should now look for long-biased trades in vTv Therapeutics if it manages to break out above some near-term overhead resistance levels at $9.96 to $10.35 a share and then above more resistance at around $11 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 101,473 shares. If that breakout gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance level at $14 a share.

Traders can look to buy vTv Therapeutics off weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at $8.27 a share. One can also buy this stock off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

A movie production player that's quickly spiking within range of triggering a big breakout trade is DreamWorks Animation SKG (DWA) , which engages in the development, production and exploitation of animated films and their associated characters worldwide. This stock has been driven lower by the sellers over the last six months, with shares off notably by 23%.

If you take a glance at the chart for DreamWorks Animation SKG, you'll notice that this stock has been uptrending over the last few weeks, with shares moving higher off its new 52-week low of $17.82 to its intraday high on Thursday of $21.16 a share. During that uptrend, shares of DreamWorks Animation SKG have been making mostly higher lows and higher highs, which is bullish technical price action. This stock broke out on Thursday above some near-term overhead resistance at $20.88 a share with decent upside volume flows. That move is now quickly pushing this stock within range of triggering another big breakout trade.

Traders should now look for long-biased trades in DreamWorks Animation SKG if it manages to break out above some near-term overhead resistance at $21.29 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 913,105 shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $23.09 to its 200-day moving average of $23.35 a share, or even $25 to $27 a share.

Traders can look to buy DreamWorks Animation SKG off weakness to anticipate that breakout and simply use a stop that sits right around its 20-day moving average of $19.78 or near more key support at $19.11 a share. One could also buy this stock off strength once it starts to take out those breakout levels with volume and then simply use a stopthat sits a comfortable percentage from your entry point.

Seres Therapeutics

Image placeholder title

Another microbiome therapeutics platform player that's starting to spike within range of triggering a major breakout trade is Seres Therapeutics (MCRB) - Get Report , which focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. This stock has been hit a bit by the sellers over the last three months, with shares down by 15.4%.

If you take a glance at the chart for Seres Therapeutics, you'll notice that this stock has been uptrending over the last month and change, with shares moving from its low of $34.50 to its recent high of $44 a share. During that uptrend, this stock has been making mostly higher lows and higher highs, which is bullish technical price action. Shares of Seres Therapeutics broke out on Thursday above some near-term resistance at $42.56 a share with lighter-than-average volume. That breakout is now quickly pushing this stock within range of triggering a much bigger breakout trade above some key near-term overhead resistance levels.

Traders should now look for long-biased trades in Seres Therapeutics if it manages to break out above near-term overhead resistance levels at $44 to around $45.50 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 388,796 shares. If that breakout begins soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $51 to its all-time high of $51.40 a share.

Traders can look to buy Seres Therapeutics off weakness to anticipate that breakout and simply use a stop that sits right around its 20-day moving average of $40.03 a share or near more key support at $39.88 a share. One can also buy this stock off strength once it starts to spike above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Another independent oil and natural gas player that's starting to trend within range of triggering a major breakout trade is Goodrich Petroleum (GDP) - Get Report , which engages in the exploration, development and production of oil and natural gas. This stock has been annihilated by the bears over the last three months, with shares down huge by 77.7%.

If you take a glance at the chart for Goodrich Petroleum, you'll notice that this stock has been downtrending badly for the last five months, with shares crashing lower off its high of $4.45 to its new 52-week low of around 56 cents. During that downtrend, shares of Goodrich Petroleum have been consistently making lower highs and lower lows, which is bearish technical price action. That said, this stock has recently started to rebound sharply higher off that 56 cents per share low and it's now quickly moving within range of triggering a major breakout trade above some key near-term overhead resistance levels.

Traders should now look for long-biased trades in Goodrich Petroleum if it manages to break out above some key near-term overhead resistance levels at 95 to 98 cents per share and then above more resistance at $1 to its 50-day moving average of $1.08 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 2.78 million shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.16 to $1.20, or even $1.40 to $1.75 a share.

Traders can look to buy Goodrich Petroleum off weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at just below 75 cents per share. One can also buy this stock off strength once it starts to bust above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Aimmune Therapeutics

Image placeholder title

My final breakout trading prospect is clinical-stage biopharmaceutical player Aimmune Therapeutics (AIMT) - Get Report , which engages in the development of desensitization treatments for peanut and other food allergies. This stock is down modestly over the last three months, with shares off by just 2.3%.

If you look at the chart for Aimmune Therapeutics, you'll notice that this stock has been uptrending over the last few weeks, with shares moving higher off its low of $18.47 to its intraday high on Thursday of $24 a share. During that uptrend, shares of Aimmune Therapeutics have been making mostly higher lows and higher highs, which is bullish technical price action. This stock broke out on Thursday above some key near-term overhead resistance at $23.40 a share with decent upside volume flows. That move is now quickly pushing this stock within range of triggering a much bigger breakout trade above a key downtrend line.

Traders should now look for long-biased trades in Aimmune Therapeutics if it manages to break out above a key downtrend line that will trigger over some key resistance levels at $24 to $25 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action 272,132 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at around $26 to $27, or even its all-time high of $28.33 a share.

Traders can look to buy Aimmune Therapeutics to anticipate that breakout and simply use a stop that sits right below some key near-term support levels $20.51 to around $20 a share. One can also buy this stock off strength once it starts to rip above those breakout levels with volume and then simply use a stop that sits a conformable percentage from your entry point.

This article is commentary by an independent contributor. At the time of publication, the author held TK positions in the stocks mentioned.